Early in 2024, we reported on the FDA's call for new boxed warnings on the labeling of all approved chimeric antigen receptor ...

Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.

Patients with liver tumors that meet the following may be candidates: The tumor is less than 4 centimeters in size Have three or fewer tumors The tumor is in a favorable location for treatment Talk to ...

KT-333 is under clinical development by Kymera Therapeutics and currently in Phase I for Unspecified B-Cell Lymphomas. According to GlobalData, Phase I drugs for Unspecified B-Cell Lymphomas does not ...

Linperlisib is under clinical development by Shanghai Yingli Pharmaceutical and currently in Phase I for Hematological Tumor.

There, a multidisciplinary team assembled to get Bridget back on the field. Spinal cord tumors are also classified by cell type. A pathologist will examine the cells microscopically and assign a grade ...

The regulator has also mandated the disclosure of granular details of all entities that hold ownership, economic interest or control in ODIs. This is applicable to ODI subscribers who have ...

Tumors are the result of abnormal cell growth. Usually, the cells in your body grow and divide to form new cells whenever your body needs them. When older cells die, they’re replaced by new ones.